AR and carcinoma: A total expression score for androgen receptors (both in basaloid and hepatoid cells) reached 7.50 ± 2.39 in the adenoma group, 5.75 ± 1.86 in the epithelioma group and 4.20 ± 3.19 in the carcinoma group and the differences were significant between the adenoma and carcinoma groups (p = 0.04) and between the adenoma and epithelioma groups (p = 0.05; Table 1 and Figure 2).